Poster Session 1: Immunosuppression
1 October 2014
Parallel 14: Outcomes in Cirrhosis
1 October 2014
Transplant Plenary II
1 October 2014
Long‐term results of combined liver‐kidney transplantation for primary hyperoxaluria type 1: The French Experience
Philippe Compagnon, Philippe Metzler, Didier Samuel, Christophe Camus, Patrick Niaudet, Antoine Durrbach, Philippe Lang, Daniel Azoulay, Christophe Duvoux, Francois Bayle, Joseph Rivalan, Pierre Merville, Gerard Pascal, Eric Thervet, Albert Bensman, Lionel Rostaing, Georges Deschenes, Jeff Morcet, Cyrille Feray, Karim Boudjema – 30 September 2014 – Primary hyperoxaluria type 1 (PH1) is a hepatic metabolic defect leading to end‐stage renal failure. The posttransplant recurrence of kidney disease can suggest a need for combined liver‐kidney transplantation (LKT).
Successful living donor liver transplantation with cavoportal hemitransposition in diffuse portomesenteric thrombosis
Manish Srivastava, Vinay Kumaran, Samiran Nundy, Naimish Mehta – 30 September 2014
Differences in long‐term survival among liver transplant recipients and the general population: A population‐based nordic study
Fredrik Åberg, Mika Gissler, Tom H. Karlsen, Bo‐Göran Ericzon, Aksel Foss, Allan Rasmussen, William Bennet, Michael Olausson, Pål‐Dag Line, Arno Nordin, Annika Bergquist, Kirsten Muri Boberg, Maria Castedal, Christian Ross Pedersen, Helena Isoniemi – 29 September 2014 – Dramatic improvement in first‐year outcomes post‐liver transplantation (LT) has shifted attention to long‐term survival, where efforts are now needed to achieve improvement. Understanding the causes of premature death is a prerequisite for improving long‐term outcome.